Evidence map›Paper›PMID 25709814›Full record

ArticleJournal of materials chemistry. B2014

A Dual Gold Nanoparticle System for Mesenchymal Stem Cell Tracking.

L M Ricles, S Y Nam, E A Treviño, S Y Emelianov, L J Suggs

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of materials chemistry. B, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. ACS nano · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. ACS nano · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. In vivo tracking ofScientific reports · 2021
    Article
  12. Neurophotonics · 2020
    Article
  13. Review
  14. Review
  15. ACS nano · 2019
    Article
  16. Photoacoustic properties of anterior ocular tissues.Journal of biomedical optics · 2019
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

L M RiclesDepartment of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712.
S Y NamDepartment of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712. ; Department of Electrical and Computer Engineering, University of Texas at Austin, Austin, TX 78712.
E A TreviñoDepartment of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712.
S Y EmelianovDepartment of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712. ; Department of Electrical and Computer Engineering, University of Texas at Austin, Austin, TX 78712.
L J SuggsDepartment of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712.

Funding

Nanotracer Development to Track Stem Cell TherapyR01EB015007 · NIBIB · UNIVERSITY OF TEXAS AT AUSTIN · PI SUGGS, LAURA J · 2012 to 2020
$3.7M
NIBIB NIH HHS R01 EB015007
6 · The paper itself

Abstract

Stem cell-based therapies have demonstrated improved outcomes in preclinical and clinical trials for treating cardiovascular ischemic diseases. However, the contribution of stem cells to vascular repair is poorly understood. To elucidate these mechanisms, many have attempted to monitor stem cells following their delivery

Identifiers

PMID25709814
PMCPMC4335651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.